trial of two management policies that resulted in contrasting patterns of perineal trauma to test some of these hypotheses more formally. The response rate of 67% partly reflected the high mobility of the women in the original study. Responders differed from non-responders in several respects-for example, they were more likely to be married. There was no evidence, however, of a differential response rate from women in the two trial groups, and the responders seemed comparable in the two groups with similar patterns of trauma and short term morbidity to those in the total trial population. Similar proportions ofwomen had had more babies in the intervening three years. Women whose index deliveries had been managed with a restricted use ofepisiotomy seemed less likely to have episiotomies or require perineal suturing at subsequent deliveries. Both these differences are fairly likely to have been due to chance.
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There was no clear difference between the groups in respect of dyspareunia. There was also no difference in the prevalence of urinary incontinence, even when the severity and nature of the incontinence, and subsequent deliveries, were taken into account.
We recognise that a more precise instrument for measuring long term morbidity associated with perineal trauma and pelvic floor relaxation might have shown differences between the two groups that our questionnaires failed to identify. Given the dispersion ofthe women since the original trial (questionnaires were returned from as far afield as Hong Kong, Singapore, California, Jamaica, and the Gulf States), there was no alternative to a postal questionnaire. Morbidity is difficult to measure in this way, but in the context of the trial we can see no reason why our measurements should have been biased. Most of the women had forgotten the details of the study by the time we recontacted them.
Ideally we should recontact the women in another 10 or more years to assess morbidity from genital prolapse, but given the difficulties we had in tracking down the 67% only three years after the event we are not sure how feasible such a study would be. The importance of asymptomatic infection and atypical illness in the transmission ofpertussis is disputed. Fine and Clarkson suggested that such infection in vaccinated children and adults is commonly transmitted to infants and young children. ' We studied the transmission ofpertussis within 26 families during an epidemic to determine the incidence of asymptomatic infection and atypical illness in children and adults and how commonly such infection is a source of illness for other family members.
Forty three children and 11 parents had typical pertussis, defined as prolonged paroxysmal cough with whoop, vomiting, or apnoea. Five children and 12 parents had atypical pertussis, defined as brief non-paroxysmal cough without whoop, vomiting, or apnoea, which occurred within 20 days after the onset of typical symptoms of pertussis in another family member (table) . Four children with typical pertussis and three children with atypical pertussis had received at least two pertussis vaccinations. Nineteen parents but no children remained asymptomatic.
In four families a parent was the first member with symptoms and presumably responsible for transmitting pertussis to the children. Of these four parents, three had typical and only one atypical pertussis. In the 22 other families the first family Incidence ofpertussis in 90 members of26families in which at least one child had typicalpertussis, and numberfrom whom Bordetella pertussis was isolated. Numbers in parentheses are those members who had received two or more pertussis vaccinations 
Patients, methods, and results
During a large survey of serological responses to infection with Bordetella pertussis in patients with pertussis and their close contacts we recruited 26 families (42 parents and 48 children) in which we were able to obtain clinical data on all family members. The families were seen in hospital and general practice in south west London from July 1985 to January 1987, and all ofthem included at least one member with typical pertussis. Families were followed up for from four to 44 weeks (mean 13 weeks) after presentation. member with symptoms was a child with typical pertussis. Of the subjects exposed to pertussis by a family member, all children less than 4 years old developed typical pertussis; in contrast, five of 10 older children and 11 of 38 parents developed atypical pertussis.
B pertussis was isolated from 14 of 39 children and from three of 32 parents from whom nasopharyngeal swabs were taken. The table shows the numbers of swabs thatwere positive on culture. Positive cultures were more common in unvaccinated children (12/29) than in children who had been vaccinated at least once (2/10).
Comment
In this study children were more commonly exposed to pertussis by a sibling (22/26) than a parent, and 25 ofthe 26 children and adults responsible for transmitting the infection had typical disease. Atypical disease occurred in older children and parents but was almost exclusively associated with secondary rather than primary infection. Furthermore, isolation of B pertussis (which may reflect a person's infectiousness) was more common in those with typical pertussis (l6 of46 who had swabs taken) than in those who were asymptomatic or had atypical pertussis (one of 25 who had swabs taken). These results could not have -been influenced by erythromycin treatment as the only family members treated in this way were children with typical pertussis (17/43).
We suggest that pertussis is most commonly transmitted by subjects with typical disease and that atypical disease and asymptomatic infection are not an important source of pertussis in this community. Thus a greater uptake of pertussis vaccination would probably affect transmission of the disease sufficiently to reduce its incidence.
We thank the doctors who referred families for investigation; the hospital microbiology laboratory for culturing the nasopharyngeal swabs; and Dr N Noah, consultant epidemiologist, Communicable Disease Surveillance Centre, Colindale, for valuable advice. MGT is supported by a grant from the Department of Health and Social Security. Near fatal drug interactions with methotrexate given for psoriasis Methotrexate and trimethoprim are folate antagonists which, given to-gether5 may produce a synergistic effect on folate metabolism. Non-steroidal anti-inflammatory drugs may also interact with methotrexate. I We describe a patient who developed necrotic skin ulceration and pancytopenia after concurrent administration of methotrexate, trimethoprim, and naproxen.
Case report
An 80 year old woman with a 24 year history of psoriasis was started on intramuscular methotrexate in June 1986 because her psoriasis had deteriorated. Treatment with oral methotrexate in 1%7-8 had been discontinued because of a slight increase in serum transaminase activities; since then she had been managed with topical steroids and tar.
From June to September 1986 she received three 15 mg injections of methotrexate. Two more (25 mg each) were given in October and November. The sixth injection (25 mg methotrexate) was given in January 1987, seven weeks after the fifth. Concurrent therapy was naproxen, 250 mg twice daily, which she had started in August 1986, before the second methotrexate injection.
Renal function was unremarkable in June 1986 (urea 8-6 mmol/l, creatinine 99 pmol/l). Before the sixth injection the blood count was normal (haemoglobin 120 g/l, white cell count 9 4x 109/1, and platelet count 219x 109/1); five days later, however, she presented with painful, ulcerated areas and contact bleeding over the thighs, buttocks, back, and upper chest (figure). Five days before the sixth injection she had started taking trimethoprim 200 mg twice daily for a urinary tract infection. Investigation showed severe neutropenia (white cell count 0 9x 109/l, neutrophils 0 3x109/l, haemoglobin 114 g/l, and platelet count 200x109/l), slightly raised urea concentration (13-3 mmol/l), and a red cell folate concentration of 504 y&/l (nornial 125-600 sg/l). We considered that the methotrexate and trimethoprim had interacted, producing skin ulceration and leucopenia.
Folinic acid 60 mg daily was started. The white cell count rose to 3-5 x 109/l by day 7; the platelet count fell to 36x 109/1 but recovered and was normal from day 9. The urea concentration rose by day 3 owing to dehydration (urea 20*2 mmol/l, creatinine 99 plmol/l), and folinic acid was continued to cover delayed excretion of methotrexate. The skin healed and contact bleeding had stopped by day 7. The urea concentration was normal on day 8 (5 3 mmol/l).
On day 8, when still neutropenic (neutrophils 1 7x 109/l), she developed pneumonia. She received gentamicin, piperacillin, and metronidazole and dobutamine for cardiogenic shock. She was comatose for about 24 hours, but by day 10 she was conscious and well perfused. The white cell count was then 15 3x 109/1. Folinic acid, metronidazole, and dobutamine were stopped, and she continued taking oral antibiotics.
Her recovery was complicated by temporary renal impairment and an acute confusional state lasting about 10 days. She was discharged one month later.
Comment
The recommended intramuscular dose ofmethotrexate in psoriasis is 7 5-50 mg weekly.2 In this case a full blood count was normal before each methotrexate injection.
Methotrexate is excreted unchanged, principally through the kidneys by glomerular filtration and active secretion,2 and impaired renal function may necessitate a reduced dosage. Our patient gave no suggestion of impaired renal function before the sixth injection of methotrexate, although she had had a urinary tract infection. ....:~~~~~~~~~~~~~~.
Skin ulceration over buttocks.
Methotrexate inhibits dihydrofolate reductase, and the erythrocyte concentration of folate is significantly decreased in psoriatic patients treated with long term methotrexate.3 Changes in mean corpuscular volume and haemoglobin concentration do not occur until folate deficiency is pronounced, however,3 and frank megaloblastic anaemia is rare.4 Our patient had a normal red cell folate value, but a single estimation is inadequate for a firm diagnosis of folate deficiency without a pretreatment reference level.3
Trimethoprini competitively inhibits bacterial dihydrofolate reductase at a different site from methotrexate. It has low affinity for human dihydrofolate reductase but may produce haematological side effects in patients with folate or vitamin B12 deficiency.
Non-steroidal anti-inflammatory drugs may interact with methotrexate.' Naproxen is highly protein bound, and administering methotrexate and naproxen together may therefore increase the unbound level of both drugs owing to their displacement from plasma protein. Because methotrexate and naproxen are both excreted by active tubular secretion, an interaction may also occur at this site, reducing the renal clearance of methotrexate. Our patient had taken naproxen for six months before admission, however, and had received four doses of methotrexate uneventfully.
Acute ulceration ofthe skin is a rare complication ofmethotrexate therapy which may occur when the dose is within the therapeutic range.5 Among seven psoriatic patients with such ulceration six were also taking a nonsteroidal anti-inflammatory drug.5
In this case, although deteriorating psoriasis, non-steroidal anti-inflammatory drug therapy, and an undetected deterioration in renal function may have been cofactors, methotrexate toxicity was probably precipitated by concurrent treatment with trimethoprim. This case emphasises the need for care when prescribing for patients receiving methotrexate.
We thank Miss J Maine, pharmacy department, Royal Liverpool Hospital, for helpful advice.
